Physician profile
Mithun Gopal Devraj
NPI 1396127205
$14,907.98
in general payments reported to CMS, 2019-2025
25 companies · $5,020 in 2025
The $5,020 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $24.97 · 2021: $150 · 2022: $1,720 · 2023: $3,400 · 2024: $4,181 · 2025: $5,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,940 · Travel and Lodging: $4,659 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,940.20 |
| Travel and Lodging | $4,659.42 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,358.15 | 2023-2025 | Corevalve Evolut R, Onyx Frontier |
| Boston Scientific Corporation | $3,013.24 | 2019-2025 | Avvigo Guidance System, General - Therapies, Crossboss |
| Abbott Laboratories | $2,535.50 | 2020-2025 | Optis, Dragonfly Opstar, Perclose Proglide |
| Edwards Lifesciences Corporation | $1,321.61 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $871.78 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $456.69 | 2022 | |
| Abiomed | $311.61 | 2023-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $297.53 | 2019-2025 | Camzyos, Eliquis |
| Asahi Intecc USA, INC. | $117.54 | 2023 | Asahi Ptca Guide Wire |
| Kiniksa Pharmaceuticals International, Plc | $73.66 | 2024 | Arcalyst |
| Novo Nordisk INC | $65.87 | 2022-2025 | Wegovy |
| Cook Medical LLC | $60.38 | 2023-2025 | Tornado, Cook Celect, Torcon Nb |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $59.87 | 2025 | Lifevest |
| Amgen INC. | $59.29 | 2023-2025 | Repatha, Repatha |
| Kiniksa Pharmaceuticals, LTD. | $46.72 | 2023 | Arcalyst |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $40.38 | 2025 | |
| Medtronic Vascular, INC. | $33.26 | 2019 | |
| Philips North America LLC | $25.81 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.07 | 2025 | |
| Janssen Pharmaceuticals, INC | $24.39 | 2023 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $23.31 | 2024 | Uptravi, Opsumit |
| Lexicon Pharmaceuticals, INC. | $22.39 | 2024 | |
| Recor Medical INC | $22.15 | 2025 | Paradise Ultrasound Renal Denervation System |
| W. L. Gore & Associates, INC. | $21.81 | 2023 | Gore Excluder Aaa Endoprosthesis |
| Pfizer INC. | $19.97 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mithun Devraj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.